Related Experiment Video

Updated: Jun 29, 2026

A Large Animal Model for Acute Kidney Injury by Temporary Bilateral Renal Artery Occlusion
09:02

A Large Animal Model for Acute Kidney Injury by Temporary Bilateral Renal Artery Occlusion

Published on: February 2, 2021

[Diuretics for acute kidney injury. Is there a rationale for their administration?]

R Lombardi1

  • 1Direttore del Dipartimento di Medicina Critica, IMPANSA Docente Onorario del Centro di Nefrologia, Facolta' di Medicina, Universita' della Repubblica, Montevideo, Uruguay. rlombard@mednet.org.uy

Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia
|October 2, 2008
PubMed

Insights

Preventing acute kidney injury (AKI) requires careful drug selection. While diuretics like furosemide and mannitol have been studied, they show limited benefit in preventing AKI in humans.

Area of Science:

  • Nephrology
  • Critical Care Medicine
  • Pharmacology

Context:

  • Acute kidney injury (AKI) is a common and serious condition across diverse clinical settings.
  • Early detection and intervention are crucial to prevent severe complications and mortality.
  • Current preventive strategies offer limited success, with volume expansion and avoiding nephrotoxins being the only proven methods.

Purpose:

  • To review the efficacy of various interventions, particularly diuretics, in preventing acute kidney injury (AKI).
  • To evaluate the role of loop diuretics (furosemide) and mannitol in AKI prevention.
  • To explore the potential of newer agents like natriuretic peptides in mitigating AKI incidence.

Summary:

  • Diuretics like furosemide and mannitol have been investigated for AKI prevention due to their renal effects, but clinical trials show no significant benefit in humans.
  • Furosemide's experimental benefits in preventing AKI have not translated to clinical success, with some evidence suggesting potential renal impairment.
  • Mannitol also induces diuresis but fails to reduce AKI incidence.
  • Natriuretic peptides (h-ANP, nesiritide) show promise in reducing AKI in cardiac surgery patients, warranting further investigation.

Impact:

  • Highlights the limited efficacy of commonly studied diuretics in preventing AKI, challenging previous assumptions.
  • Identifies natriuretic peptides as a potential novel therapeutic avenue for AKI prevention, particularly in high-risk surgical populations.
  • Emphasizes the need for larger, robust clinical trials to validate the protective effects of natriuretic peptides against AKI.

Related Concept Videos

Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Acute Kidney Injury VI: Nursing Management01:22

Acute Kidney Injury VI: Nursing Management

Acute Kidney Injury (AKI) results in an inability to maintain fluid, electrolyte, and acid-base balance. Effective nursing management is critical in improving patient outcomes and includes comprehensive patient assessment and targeted interventions.Comprehensive Patient AssessmentA detailed history collection is essential, focusing on any recent infections, nephrotoxic medication use, or chronic conditions such as hypertension and diabetes that may contribute to AKI. During the physical...
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...